This trial is withdrawn!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Ischemic Stroke or Hypothermia
and you are
between 18 and 79
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether reducing a patient's body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients who have suffered a significant interruption of blood flow to an area of brain (occlusion of large proximal cerebral artery) and have undergone successful removal of that interruption (revascularization).This will be achieved by comparing patients who have undergone hypothermia to those who have not.

Provided treatments

  • Procedure: Normothermia
  • Procedure: Mild hypothermia
  • Device: Trevo Pro Retriever (Stryker Corp.)
  • Device: Zoll Thermogard XP technology with the Quattro catheter
Tris trial is registered with FDA with number: NCT02411877. The sponsor of the trial is WellStar Health System and it is looking for 0 volunteers for the current phase.
Official trial title:
REperfusion With Cooling in CerebraL Acute IscheMia II